News/ US Alexion appoints former Baxalta chief Hantson as CEO Richard Staines Alexion, Baxalta, Shire, ultra-orphan, ultra-rare diseases 0 Comment Former AZ chief David Brennan expected to take over as chairman in May. Share X Alexion appoints former Baxalta chief Hantson as CEO https://pharmaphorum.com/news/alexion-appoints-former-baxalta-chief-hantson-ceo/
News Shire’s Onivyde pancreatic cancer drug approved in EU Richard Staines Baxalta, cancer, Merrimack, pancreatic cancer, Shire 0 Comment Drug approved in metastatic adenocarcinoma of the pancreas. Share X Shire’s Onivyde pancreatic cancer drug approved in EU https://pharmaphorum.com/news/shires-onivyde-pancreatic-cancer-drug-approved-eu/
News/ Sales and Marketing Newly merged Shire raises full year forecast Andrew McConaghie Baxalta, NASH, Rare diseases, Shire, specialist 0 Comment Shire buoyant thanks to growth across portfolio Share X Newly merged Shire raises full year forecast https://pharmaphorum.com/news/newly-merged-shire-raises-full-year-forecast/